Skip to content

Comparison of the effect of Myrtus herbal mouthwash versus chlorhexidine mouthwash on the prevention of Ventilator Associated Pneumonia

Comparison of the effect of Myrtus herbal mouthwash versus chlorhexidine mouthwash on the prevention of Ventilator Associated Pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200705048006N1
Enrollment
70
Registered
2020-08-03
Start date
2020-09-21
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator Associated Pneumonia. Diseases of the respiratory system:pneumonia

Interventions

Intervention 1: Intervention group: The intervention group receives oral care with the herbal mouthwash for 5 days and three times a day by the same method by the researcher. Other care will be the sa

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The main caregiver of the patient should be consciously satisfied to participate in the research (due to the disorder in the patient's level of consciousness) The patient's age should be between 70-18 years Immunosuppressive diseases and underlying lung disease are not recognized by the treating physician Do not have a specific lesion in or around the mouth Has no history of allergy to herbal ingredients (according to the history obtained from the patient's primary caregiver) Under mechanical ventilation through the endotracheal tube At the time of hospitalization in the ICU and intubation, there is no evidence of pneumonia in chest radiography at the discretion of the treating physician Must be mechanically ventilated for at least the next 48 hours (according to the definition of Ventilator Associated Pneumonia)

Exclusion criteria

Exclusion criteria: Withdrawal of the patient's primary caregiver from continuing the study Transfer or death of the patient, removal of the endotracheal tube before 48 hours Allergic reaction to mouthwash Observation of obvious aspiration (observation of gastric material during endotracheal tube suction, change of position, cough, etc.) Do not have an upper airway infection (based on your doctor's diagnosis)

Design outcomes

Primary

MeasureTime frame
Prevention of Ventilator Associated Pneumonia. Timepoint: Before the intervention and the fifth day after the intervention. Method of measurement: Clinical Pulmonary Infection Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Farahmand Nasab

Mashhad University of Medical Sciences

FarahmandNA961@mums.ac.ir+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026